5-fluoro-4-(4-fluoro-2-methoxyphenyl)-N-{4-[(methylsulfonyl)methyl]pyridin-2-yl}pyridin-2-amine | 1602485-98-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 5-fluoro-4-(4-fluoro-2-methoxyphenyl)-N-{4-[(methylsulfonyl)methyl]pyridin-2-yl}pyridin-2-amine
• 英文别名: US9670161, 1 5-Fluoro-4-(4-fluoro-2-methoxyphenyl)-N-{4-[(methylsulfonyl)methyl]pyridin-2-yl}pyridin-2-amine；5-fluoro-4-(4-fluoro-2-methoxyphenyl)-N-[4-(methylsulfonylmethyl)pyridin-2-yl]pyridin-2-amine
• CAS: 1602485-98-2
• 化学式: C₁₉H₁₇F₂N₃O₃S
• 分子量: 405.425
• InChiKey: VRHHAMWTRSVIEX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  28
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.16
• 拓扑面积：
  89.6
• 氢给体数：
  1
• 氢受体数：
  8

反应信息

• 作为产物：
  描述：

  N-[4-(chloromethyl)pyridin-2-yl]-5-fluoro-4-(4-fluoro-2-methoxyphenyl)pyridin-2-amine 在 potassium permanganate 作用下， 以 乙醇 、 丙酮 为溶剂， 反应 5.75h， 生成 5-fluoro-4-(4-fluoro-2-methoxyphenyl)-N-{4-[(methylsulfonyl)methyl]pyridin-2-yl}pyridin-2-amine
  参考文献：
  名称：

  [EN] 5-FLUORO-N-(PYRIDIN-2-YL)PYRIDIN-2-AMINE DERIVATIVES CONTAINING A SULFONE GROUP
  [FR] DÉRIVÉS 5-FLUORO-N-(PYRIDIN-2-YL)PYRIDIN-2-AMINE CONTENANT UN GROUPE SULFONE

  摘要：

  公开号：

  WO2014060375A3

文献信息

• 5-FLUORO-N-(PYRIDIN-2-YL)PYRIDIN-2-AMINE DERIVATIVES CONTAINING A SULFONE GROUP
  申请人：BAYER PHARMA AKTIENGESELLSCHAFT

  公开号：US20150274666A1

  公开（公告）日：2015-10-01

  The present invention relates to 5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group of general formula (I) as described and defined herein, and methods for their preparation, their use for the treatment and/or prophylaxis of disorders, in particular of hyper-proliferative disorders and/or virally induced infectious diseases and/or of cardiovascular diseases. The invention further relates to intermediate compounds useful in the preparation of said compounds of general formula (I).

  本发明涉及一种含有磺酰基的5-氟-N-(吡啶-2-基)吡啶-2-胺衍生物，其一般式（I）如本文所述和定义的，以及它们的制备方法，它们用于治疗和/或预防疾病，特别是高增殖性疾病和/或病毒引起的传染病和/或心血管疾病。本发明还涉及用于制备所述一般式（I）化合物的中间体化合物。
• EP2909176A2
  申请人：——

  公开号：EP2909176A2

  公开（公告）日：2015-08-26
• METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE
  申请人：Design Therapeutics, Inc.

  公开号：US20210238226A1

  公开（公告）日：2021-08-05

  The present disclosure relates to compounds and methods for modulating the expression of dmpk, atxn1, atxn2, atxn3, cacna1a, atxn7, ppp2r2br tbp, htt, jph3r ar, or atn1 and treating diseases and conditions in which dmpk, atxn1, atxn2, atxn3, cacna1a, atxn1, ppp2r2b, tbp, htt, jph3, ar, or atn1 plays an active role. The compound can be a transcription modulator molecule having a first terminus, a second terminus, and oligomeric backbone, wherein: a) the first terminus comprises a DNA-binding moiety capable of noncovalently binding to a nucleotide repeat sequence CAG or CTG; b) the second terminus comprises a protein-binding moiety binding to a regulatory molecule that modulates an expression of a gene comprising the nucleotide repeat sequence CAG or CTG; and c) the oligomeric backbone comprising a linker between the first terminus and the second terminus.
• US9670161B2
  申请人：——

  公开号：US9670161B2

  公开（公告）日：2017-06-06
• [EN] 5-FLUORO-N-(PYRIDIN-2-YL)PYRIDIN-2-AMINE DERIVATIVES CONTAINING A SULFONE GROUP<br/>[FR] DÉRIVÉS 5-FLUORO-N-(PYRIDIN-2-YL)PYRIDIN-2-AMINE CONTENANT UN GROUPE SULFONE
  申请人：BAYER PHARMA AG

  公开号：WO2014060375A3

  公开（公告）日：2014-08-07